MedPage Today on MSN
Triglyceride-Lowering Drug Gets FDA Nod for Rare Genetic Disorder
The small interfering RNA (siRNA) therapy, designed to reduce triglyceride levels by suppressing production of apolipoprotein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback